Nanostim-leadless pacemaker.
Sperzel J, Hamm C, Hain A.
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):327-333. doi: 10.1007/s00399-018-0598-3. Epub 2018 Oct 19.
Leadless pacing.
Sperzel J, Hamm C, Hain A.
Herz. 2018 Nov;43(7):605-611. doi: 10.1007/s00059-018-4752-9.
Longitudinal changes in intracardiac repolarization lability in patients with implantable cardioverter-defibrillator.
Guduru A, Lansdown J, Chernichenko D, Berger RD, Tereshchenko LG.
Front Physiol. 2013 Aug 12;4:208. doi: 10.3389/fphys.2013.00208. eCollection 2013.
Strong coherence between heart rate variability and intracardiac repolarization lability during biventricular pacing is associated with reverse electrical remodeling of the native conduction and improved outcome.
Tereshchenko LG, Henrikson CA, Berger RD.
J Electrocardiol. 2011 Nov-Dec;44(6):713-7. doi: 10.1016/j.jelectrocard.2011.07.028. Epub 2011 Sep 22.
Arrhythmias in Cardiac Amyloidosis: Challenges in Risk Stratification and Treatment.
Cheung CC, Roston TM, Andrade JG, Bennett MT, Davis MK.
Can J Cardiol. 2020 Mar;36(3):416-423. doi: 10.1016/j.cjca.2019.11.039. Epub 2019 Dec 12.
Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
J Am Coll Cardiol. 2011 Sep 27;58(14):1485-96. doi: 10.1016/j.jacc.2011.06.043.
Automatic Internal Cardiac Defibrillator.
Iqbal AM, Butt N, Jamal SF.
2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
[Current impact of cardiac implantable electronic devices].
Kuschyk J, Rudic B, Borggrefe M, Akin I.
Herz. 2017 Apr;42(2):151-161. doi: 10.1007/s00059-017-4548-3.
Strategies to prevent infections associated with cardiovascular implantable electronic devices.
Palraj BR, Farid S, Sohail MR.
Expert Rev Med Devices. 2017 May;14(5):371-381. doi: 10.1080/17434440.2017.1322506. Epub 2017 May 4.
Preventive implantable cardioverter defibrillator therapy in contemporary clinical practice: need for more stringent selection criteria.
Deckers JW, Arshi B, van den Berge JC, Constantinescu AA.
ESC Heart Fail. 2021 Oct;8(5):3656-3662. doi: 10.1002/ehf2.13506. Epub 2021 Aug 1.
